BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  Israel to Work with Teva to Keep More Jobs

  The Israeli government isn’t considering punitive measures against debt-strapped Teva over its plan to fire a quarter of its Israeli work force, according to an official close to Prime Minister Benjamin Netanyahu.

  December 18, 2017

   · 

  1 min read
• 

  Drug Development

  12 Clinical Successes of 2017

  Now that we’ve got the bad news out of the way, we’re here to spread some Christmas cheer with the biggest clinical successes in biotech over the past 12 months.

  December 18, 2017

   · 

  1 min read
• 

  Deals

  Novartis Buys Rare Drug Voucher for $130M From Ultragenyx

  Ultragenyx CEO Emil Kakkis said the sale of the PRV will provide the company with an “important source of non-dilutive capital” that will be used to advance the company’s pipeline of rare and ultra-rare therapies.

  December 18, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Biotech Bay

  8 Possible Biopharma Takeover Targets for 2018

  The possibility of a tax bill being passed has many investors and analysts forecasting 2018 to be a big year for mergers and acquisitions.

  December 18, 2017

   · 

  5 min read

   · 

  Mark Terry
• 

  Biotech Bay

  Bay Area Bigfoot Biomedical Bags $37M Series B Financing

  The round was co-led by funds managed by new investor Janus Henderson Investors.

  December 18, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  FDA

  Aerie’s Glaucoma Drug Scores Early FDA Approval

  Christmas came a week early for Aerie Pharmaceuticals.

  December 18, 2017

   · 

  2 min read

   · 

  Alex Keown
• Pharm Country

  Accelerate NY Seed Fund Awards Bioharmony Therapeutics $100,000 to Develop a Lysin-based Treatment for Skin Infections Caused by Multi-drug Resistant Acinetobacter baumanii

  ANY invested $100,000 in the company’s seed round.

  December 18, 2017

   · 

  4 min read
• 

  FDA

  Spectral’s Proprietary Stand-Alone Pump Wins FDA 510(k) Clearance

  Spectral Medical today announced that the FDA has granted 510(k) clearance for the Spectral Apheresis Machine for use in continuous renal replacement therapy and therapeutic plasma exchange.

  December 18, 2017

   · 

  3 min read
• Deals

  Isodiol to Snap Up Biosynthesis Pharma Group

  The BSPG acquisition includes multiple entities that are strategic to the future of Isodiol.

  December 18, 2017

   · 

  5 min read
• Drug Development

  Stealth BioTherapeutics Granted Fast Track Designation for Elamipretide for the Treatment of Leber’s Hereditary Optic Neuropathy

  Top-line results from the study are expected by mid-2018.

  December 18, 2017

   · 

  3 min read